PMMI ProSource – Start Your Search
Check out our packaging and processing solutions finder, PMMI ProSource.

GlobalData

From GlobalData
GlobalData analyst says two-year suspension will provide relief to small- and medium-sized device makers.
Medical Device Excise Tax Suspension to Rejuvenate U.S. Market
GlobalData analyst says two-year suspension will provide relief to small- and medium-sized device makers.
Medical Device Excise Tax Suspension to Rejuvenate U.S. Market
The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development (R&D) in 2013, an increase of $723 million over the previous year, according to research and consulting firm GlobalData.
Top 30 pharmaceutical firms spent $112 billion on R&D in 2013
Expiries of leading drugs to cause huge financial losses for pharmaceutical firms by 2019, predicts GlobalData.
Patent cliff to cause $65 billion sales loss
GlobalData analyst says the infection has not represented an attractive investment for pharmaceutical companies.
Public-private partnerships vital to advanced Ebola treatment pipeline
GlobalData report says patent expirations of branded biologics and regulatory changes will help biosimilars gain market share from biologics.
Biosimilars to erode biologics market beyond 2019
EU flag
Determining the future of EU medical device regulations
Page 1 of 1